High throughput multi-omic cancer studies have described the inter-tumor heterogeneity and led to well defined molecular classifications. Nevertheless, these classifications only reflect the most abundant tumor subtype in the examined sample, thus neglecting intra-tumor heterogeneity, a major source of therapeutic resistance. As advanced microdissection techniques to isolate a cell population of interest from heterogeneous clinical […]
Read More